✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
首页 › 产品目录 › 富马酸伊布利特

富马酸伊布利特

CAS 122647-32-9C20H36N2O3SMW 384.6

济南圣和化工有限公司现供应有机化学品——富马酸伊布利特(CAS 122647-32-9),分子式 C20H36N2O3S,分子量 384.6。本页理化参数仅供参考,实际常规纯度 按批次COA提供(不公开发布),以批次 COA 及订单确认为准,支持批量采购与长期供货协议。

产品概览

CAS号122647-32-9
分子式C20H36N2O3S
分子量384.6
LogP4.6
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域有机化学品
类别有机化学品

应用领域

有机化学品

富马酸伊布利特主要应用于有机化学品。具体使用工况下的添加量与规格要求,欢迎与技术团队沟通确认。

包装与储存

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
运输常规化工运输
样品可协商提供
交期现货/按订单安排

供货能力:富马酸伊布利特 备有现货,包装形式为按订单/批次确认(不公开发布)。我们支持对公转账并开具增值税发票,山东省内可安排快速配送,省外按物流时效发货,具体请联系 info@591daili.com。

质量与文件

每批产品随货提供 COA(分析证书);可按需提供 MSDS/技术数据表及第三方检测报告。纯度与包装以批次 COA 及订单确认为准。

关于供应商

济南圣和化工有限公司位于山东济南,主营化工原料供应,精选产品 3,000+ 种,覆盖有机化学品、无机化学品、食品添加剂、医药中间体等 12 大分类。我们随货提供 COA 分析证书,一个工作日内回复报价,欢迎国内外采购方长期合作。

常见问题

富马酸伊布利特 的 CAS 号是多少?

富马酸伊布利特 的 CAS 号为 122647-32-9。

该产品的纯度和包装规格是什么?

常规纯度规格为 按批次COA提供(不公开发布),包装为 按订单/批次确认(不公开发布),随货提供 COA。

富马酸伊布利特 有什么用途?

主要应用于有机化学品。

如何购买或获取报价?

请发送邮件至 info@591daili.com 或通过 WhatsApp 联系,注明产品名称、CAS 号与需求数量,一个工作日内回复报价。供应商:济南圣和化工有限公司。

PubChem 公开数据

Description

Ibutilide fumarate · CAS 122647-32-9 · C20H36N2O3S. UNII 2436VX1U9B. Solubility: 100; Solubility: 4.73e-03 g/L; LogP: 4.6.

Identification

CAS Registry Number122647-32-9
PubChem CID60753
Molecular formulaC20H36N2O3S
IUPAC nameN-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide
UNII (FDA)2436VX1U9B

Computed Descriptors

Molecular Weight384.6
XLogP34
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count14
Exact Mass384.24466419
Monoisotopic Mass384.24466419
Topological Polar Surface Area78
Heavy Atom Count26
Formal Charge0

Physical & Chemical Properties

Solubility100
Solubility4.73e-03 g/L
LogP4.6

Physical description & handling notes

  • Solid
  • MW: 885.23. Crystals from acetone, mp 117-119 °C.; UV max (95% ethanol): 228, 267 nm (epsilon 16670, 894); solubility: (mg/mL): aqueous >100 (pH less than or equal to 7) /Ibutilide fumarate/
  • Parenteral: Injection, for IV infusion: 1 mg (0.1 mg/mL), Covert (Pfizer). /Ibutilide fumarate/

Documented Uses

  • The synthesis starts with a Friedel-Crafts acylation of methanesulfonanilide with succinic anhydride in presence of AlCl3 yielding 4-[(methylsulfonyl)amino]-gamma-oxobenzenebutanoic acid, which is treated with N-ethylheptylamine and dicyclohexylcarbodiimide (DCC) in DMF to give the corresponding amide. Reduction with LiAlH4 in THF in the last step provides the desired drug substance.
  • Indicated for the rapid conversion of atrial fibrillation or atrial flutter of recent onset to sinus rhythm.
  • Ibutilide is a class III antiarrhythmic medication approved by the US Food and Drug Administration (FDA) for converting acute atrial flutter and atrial fibrillation to normal sinus rhythm. Research indicates ibutilide's greater efficacy in treating atrial flutter compared to atrial fibrillation.
  • Ibutilide fumarate injection is indicated for the rapid conversion of atrial fibrillation or atrial flutter of recent onset to sinus rhythm. Patients with atrial arrhythmias of longer duration are less likely to respond to ibutilide fumarate injection. The effectiveness of ibutilide has not been determined in patients with arrhythmias of more than 90 days in duration. /Included in US product label/
  • Ibutilide is administered as a rapid infusion (1 mg over 10 minutes) for the immediate conversion of atrial fibrillation or flutter to sinus rhythm. The drug's efficacy rate is higher in patients with atrial flutter (50-70%) than in those with atrial fibrillation (30-50%). In atrial fibrillation, the conversion rate is lower in those in whom the arrhythmia has been present for weeks or months compared with those in whom it has been present for days.
  • Patients with chronic atrial fibrillation have a strong tendency to revert after conversion to sinus rhythm and treatments to maintain sinus rhythm carry risks. Patients to be treated with ibutilide fumarate injection, therefore, should be carefully selected such that the expected benefits of maintaining sinus rhythm outweigh the immediate risks of ibutilide fumarate injection, and the risks of maintenance therapy, and are likely to offer an advantage compared with alternative management.

Synonyms

Ibutilide; 122647-31-8; Ibutilida; Ibutilidum; n-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide; N-(4-(4-(ethyl(heptyl)amino)-1-hydroxybutyl)phenyl)methanesulfonamide; N-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide; 2436VX1U9B; DTXSID20861271; N-[4-[4-(ethylheptylamino)-1-hydroxybutyl]phenyl]methanesulfonamide; N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)methanesulfonamide; RefChem:56518; C01BD05; DTXCID30197270; Ibutilidum [INN-Latin]; Ibutilida [INN-Spanish]

Frequently Asked Questions

What are the CAS number and molecular formula of Ibutilide fumarate?

CAS 122647-32-9; molecular formula C20H36N2O3S; molecular weight — g/mol.

What other names is Ibutilide fumarate known by?

Ibutilide, 122647-31-8, Ibutilida, Ibutilidum, n-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide, N-(4-(4-(ethyl(heptyl)amino)-1-hydroxybutyl)phenyl)methanesulfonamide.

What are the key physical properties of Ibutilide fumarate?

Solubility: 100; Solubility: 4.73e-03 g/L; LogP: 4.6.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

获取报价

✉ info@591daili.com☎ +86-18553102138📞 WhatsApp邮件询价WhatsApp 询价

供应商:济南圣和化工有限公司

English page: Ibutilide fumarate

鲁ICP备19031700号-2